Article
Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood
18 Aug 2014
Abstract excerpt
BACKGROUND: Wilms tumor is the most common pediatric renal malignancy and there is a clinical need for a molecular biomarker to assess treatment response and predict relapse. The known mutated genes in this tumor type show low mutation frequencies, whereas aberrant methylation at 11p15 is by far the most common aberration. We therefore analyzed the epigenome, rather than the genome, to identify ubiquitous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
